TME Therapeutics (Biotechnology) Overview
- Year Founded
-
2018
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
TME Therapeutics (Biotechnology) General Information
Description
Operator of a stem cell research and development company intended to development of stem-cell-based cultured cell therapy. The company provides coated surfaces that support the attachment and expansion of various stem cells including mesenchymal stem cells, satellite stem cells and neural stem cells, enabling users to get products related to stem cell expansion under fully defined conditions.
Contact Information
Website
www.tmet.co.krCorporate Office
- 204, Convensia-daero
- Number 208, Insta 2 building, Incheon Startup Park
- Incheon, Yeonsu-gu
- South Korea
Corporate Office
- 204, Convensia-daero
- Number 208, Insta 2 building, Incheon Startup Park
- Incheon, Yeonsu-gu
- South Korea
TME Therapeutics (Biotechnology) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 13-Jul-2023 | Completed | Out of Business | |||
| 1. Accelerator/Incubator | Completed | Generating Revenue |
TME Therapeutics (Biotechnology) Patents
TME Therapeutics (Biotechnology) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2023158285-A1 | Gf binding ecm mimetic coated microcarrier | Inactive | 21-Feb-2022 | ||
| CA-3201919-A1 | Protein substrate to bind growth factor | Pending | 16-Dec-2020 | ||
| EP-4244241-A1 | Protein substrate to bind growth factor | Pending | 16-Dec-2020 | ||
| EP-4244241-A4 | Protein substrate to bind growth factor | Pending | 16-Dec-2020 | ||
| JP-2025061045-A | Protein substrate to bind growth factor | Active | 16-Dec-2020 | C07K14/78 |
TME Therapeutics (Biotechnology) FAQs
-
When was TME Therapeutics (Biotechnology) founded?
TME Therapeutics (Biotechnology) was founded in 2018.
-
Where is TME Therapeutics (Biotechnology) headquartered?
TME Therapeutics (Biotechnology) is headquartered in Incheon, South Korea.
-
What industry is TME Therapeutics (Biotechnology) in?
TME Therapeutics (Biotechnology)’s primary industry is Biotechnology.
-
Is TME Therapeutics (Biotechnology) a private or public company?
TME Therapeutics (Biotechnology) is a Private company.
-
What is TME Therapeutics (Biotechnology)’s current revenue?
The current revenue for TME Therapeutics (Biotechnology) is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process